Ningbo David Medical Device Yönetim

Yönetim kriter kontrolleri 2/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Zaihong Chen

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	no data
CEO sahipliği	45.8%
Yönetim ortalama görev süresi	Veri yok
Yönetim Kurulu ortalama görev süresi	5.1yrs

Son yönetim güncellemeleri

Recent updates

Ningbo David Medical Device's (SZSE:300314) Shareholders Have More To Worry About Than Only Soft Earnings

Oct 30

Earnings Tell The Story For Ningbo David Medical Device Co., Ltd. (SZSE:300314) As Its Stock Soars 28%

Sep 27

Even With A 27% Surge, Cautious Investors Are Not Rewarding Ningbo David Medical Device Co., Ltd.'s (SZSE:300314) Performance Completely

May 22

Weak Statutory Earnings May Not Tell The Whole Story For Ningbo David Medical Device (SZSE:300314)

Apr 26

Ningbo David Medical Device Co., Ltd.'s (SZSE:300314) Shares Leap 31% Yet They're Still Not Telling The Full Story

Mar 06

CEO

Zaihong Chen (55 yo)

no data

Görev süresi

CN¥789,500

Tazminat

Mr. Zaihong Chen serves as Chairman of Board at Ningbo David Medical Device Co., Ltd. and serves as its General Manager.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Zaihong Chen	GM & Chairman	no data	CN¥789.50k	45.81% CN¥ 1.6b
Zedong Li	CFO, Secretary & Director	5.1yrs	CN¥379.20k	0.34% CN¥ 11.4m
Yongwei Yu	Deputy GM & Non-Independent Director	14.3yrs	CN¥378.20k	0.30% CN¥ 10.0m
Zaiwei Chen	Vice Chairman	no data	Veri yok	20.25% CN¥ 685.8m
Ping Liu	Non-Independent Director	5.1yrs	CN¥500.80k	Veri yok
Fangfang Xu	Non-Independent Director	14.3yrs	CN¥207.30k	Veri yok
Xianquan Li	Supervisor	14.3yrs	Veri yok	Veri yok
Yaqing Zhu	Independent Director	2yrs	CN¥11.40k	Veri yok
Qingzhu Zheng	Supervisor	4.5yrs	Veri yok	Veri yok
Hong Chen	Chairman of the Supervisory Board	14.3yrs	Veri yok	Veri yok
Saifang Chen	Independent Director	2yrs	Veri yok	Veri yok
Yingying Xi	Independent Director	2yrs	CN¥11.40k	Veri yok

5.1yrs

Ortalama Görev Süresi

52yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 300314 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.1 yıldır).

Ningbo David Medical Device Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

Ningbo David Medical Device Co., Ltd., Annual General Meeting, May 30, 2024

Ningbo David Medical Device Co., Ltd., Annual General Meeting, May 30, 2024

High number of new directors

Ningbo David Medical Device Co., Ltd. Announces Executive Elections

High number of new and inexperienced directors

Ningbo David Medical Device Co., Ltd., Annual General Meeting, Mar 03, 2021

Recent updates

Ningbo David Medical Device's (SZSE:300314) Shareholders Have More To Worry About Than Only Soft Earnings

Third quarter 2024 earnings released: EPS: CN¥0.058 (vs CN¥0.11 in 3Q 2023)

Investor sentiment deteriorates as stock falls 18%

New minor risk - Share price stability

Ningbo David Medical Device Co., Ltd. to Report Q3, 2024 Results on Oct 23, 2024

Earnings Tell The Story For Ningbo David Medical Device Co., Ltd. (SZSE:300314) As Its Stock Soars 28%

Investor sentiment improves as stock rises 18%

Second quarter 2024 earnings released: EPS: CN¥0.029 (vs CN¥0.14 in 2Q 2023)

Ningbo David Medical Device Co., Ltd. to Report First Half, 2024 Results on Aug 20, 2024

Even With A 27% Surge, Cautious Investors Are Not Rewarding Ningbo David Medical Device Co., Ltd.'s (SZSE:300314) Performance Completely

Investor sentiment improves as stock rises 24%

Weak Statutory Earnings May Not Tell The Whole Story For Ningbo David Medical Device (SZSE:300314)

New major risk - Earnings quality

Ningbo David Medical Device Co., Ltd., Annual General Meeting, May 30, 2024

Ningbo David Medical Device Co., Ltd., Annual General Meeting, May 30, 2024

Full year 2023 earnings: EPS and revenues miss analyst expectations

Ningbo David Medical Device Co., Ltd. to Report Q1, 2024 Results on Apr 20, 2024

Now 20% undervalued after recent price drop

Ningbo David Medical Device Co., Ltd.'s (SZSE:300314) Shares Leap 31% Yet They're Still Not Telling The Full Story

Now 24% undervalued after recent price drop

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 27%

Now 22% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 16%

Ningbo David Medical Device Co., Ltd. to Report Fiscal Year 2023 Results on Apr 09, 2024

New minor risk - Earnings quality

Third quarter 2023 earnings released: EPS: CN¥0.11 (vs CN¥0.14 in 3Q 2022)

New minor risk - Share price stability

Second quarter 2023 earnings released: EPS: CN¥0.14 (vs CN¥0.10 in 2Q 2022)

Ningbo David Medical Device Co., Ltd. to Report Q2, 2022 Results on Aug 22, 2023

Upcoming dividend of CN¥0.15 per share at 0.8% yield

First quarter 2023 earnings released: EPS: CN¥0.17 (vs CN¥0.03 in 1Q 2022)

Investor sentiment improves as stock rises 18%

High number of new directors

Ningbo David Medical Device Co., Ltd. Announces Executive Elections

Third quarter 2022 earnings released: EPS: CN¥0.14 (vs CN¥0.001 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.10 (vs CN¥0.15 in 2Q 2021)

First quarter 2022 earnings released: EPS: CN¥0.03 (vs CN¥0.08 in 1Q 2021)

High number of new and inexperienced directors

Ningbo David Medical Device Co., Ltd. Approves Cash Dividend for 2021

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Third quarter 2021 earnings released: EPS CN¥0.001 (vs CN¥0.24 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.15 (vs CN¥0.15 in 2Q 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.08 (vs CN¥0.05 in 1Q 2020)

Investor sentiment deteriorated over the past week

Full year 2020 earnings released: EPS CN¥0.47 (vs CN¥0.22 in FY 2019)

Ningbo David Medical Device Co., Ltd., Annual General Meeting, Mar 03, 2021

New 90-day low: CN¥14.83

Investor sentiment deteriorated over the past week

Ningbo David Medical Device Co., Ltd. to Report Fiscal Year 2020 Results on Feb 09, 2021

New 90-day low: CN¥15.36

New 90-day low: CN¥18.14

Market bids up stock over the past week

Third quarter earnings released

New 90-day high: CN¥24.78

Ningbo David Medical Device Co., Ltd. to Report Q3, 2020 Results on Oct 27, 2020

Market bids up stock over the past week

Earnings released

Ningbo David Medical Device Co., Ltd. to Report First Half, 2020 Results on Aug 25, 2020

CEO

Görev süresi

Tazminat

Yönetim Kurulu Üyeleri